PROTAMINE sulphate sourced
from the Hokkaido Island fishing
areas off the coast of Japan has
been given the all clear by the
European Medicines Agency
following an extensive review.
The Agency's Committee for
Medicinal Products for Human Use
commenced the review after the
fishing grounds for wild salmon (from
which protamine sulphate is sourced)
were moved from Honshu to
Hokkaido Island (due to the
Japanese tsunami in March 2011).
This change in the source of the
raw material led to differences in
the active substance.
Following the assessment of all
available data the CHMP concluded
that these differences had no
impact on the quality of the medicine.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 12
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.